CAT-1004: Phase I/II data

Top-line data from 17 ambulatory DMD patients ages 4-7 who were steroid naive or have not use steroids for >=6 months in Part A of the open-label, dose-escalation, U.S. Phase I/II MoveDMD trial showed...